Holen Sie sich die Stockscreener-App
7.9801
2.44%
0.1901
Schlusskurs vom Vortag:
$7.79
Offen:
$7.94
24-Stunden-Volumen:
20,819
Relative Volume:
0.26
Marktkapitalisierung:
$462.03M
Einnahmen:
$154.57M
Nettoeinkommen (Verlust:
$15.07M
KGV:
29.56
EPS:
0.27
Netto-Cashflow:
$10.92M
1W Leistung:
-2.92%
1M Leistung:
+12.87%
6M Leistung:
+4.45%
1J Leistung:
+5.98%
1-Tages-Spanne:
$7.93
$8.0834
1-Wochen-Bereich:
$7.66
$8.3411
52-Wochen-Spanne:
$5.54
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Vergleichen Sie KMDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
8.01 | 449.34M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
124.18 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.97 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.66 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
470.62 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Eingeleitet | The Benchmark Company | Buy |
| 2024-07-03 | Eingeleitet | Stifel | Buy |
| 2018-02-02 | Eingeleitet | Chardan Capital Markets | Buy |
Kamada Ltd Aktie (KMDA) Neueste Nachrichten
Kamada Ltd: Biopharma under Pressure as KMDA Stock Tests Investor Patience - AD HOC NEWS
Panic Selling: Can Kamada Ltd navigate macro headwindsMarket Risk Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market - openPR.com
Is Kamada Ltd. stock a safe investment in uncertain marketsSector ETF Performance & Fast Growing Trading Plans - bollywoodhelpline.com
Kamada Ltd. (KMDA) Stock Analysis: Exploring A 58.15% Upside In The Healthcare Space - DirectorsTalk Interviews
Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio | Corporate - EQS News
Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio - NewMediaWire
Kamada Projects Strong 2026 Growth Fueled by Plasma Portfolio and Distribution Expansion - citybuzz -
Kamada shares climb after upbeat 2026 outlook points to double-digit growth - MSN
HC Wainwright Issues Optimistic Forecast for Kamada Earnings - Defense World
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN
Q1 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World
Kamada Ltd. (KMDA) Stock Analysis: Unpacking a 63.52% Potential Upside in Healthcare Innovation - DirectorsTalk Interviews
Q1 Earnings Estimate for Kamada Issued By HC Wainwright - MarketBeat
Can Kamada Ltd. stock attract ESG capital inflowsMarket Performance Recap & Low Drawdown Momentum Trade Ideas - Улправда
Benchmark reiterates Buy rating on Kamada stock, maintains $15 target By Investing.com - Investing.com Nigeria
Benchmark reiterates Buy rating on Kamada stock, maintains $15 target - Investing.com
Kamada 2025/2026 Outlook: Evaluating Revenue Growth And Product Drivers (NASDAQ:KMDA) - Seeking Alpha
Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026 - GuruFocus
Kamada forecasts double-digit profitable growth in 2026 - MSN
Kamada stock rises after issuing 2026 guidance showing double-digit growth - Investing.com Nigeria
Kamada forecasts 13% revenue growth in 2026, issues guidance - Investing.com
Kamada forecasts 13% revenue growth in 2026, issues guidance By Investing.com - Investing.com Nigeria
Kamada Provides 2026 Annual Guidance of $200$205 Million in Revenues and $50$53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance - marketscreener.com
Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Kamada Ltd. (KMDA) Stock Analysis: Unearthing an 84% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Leasing LimitedFundamental Strength Indicators & Free Exceptional ROI Methods - bollywoodhelpline.com
Kamada stock rises after issuing 2026 guidance showing double-digit growth By Investing.com - Investing.com South Africa
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World
Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN
Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga
Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com
Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда
Will Kamada Ltd. stock see insider buyingWeekly Trend Recap & Precise Entry and Exit Recommendations - Улправда
Is Kamada Ltd. stock positioned well for digital economyLayoff News & Fast Exit and Entry Strategy Plans - Улправда
Can Kamada Ltd. stock resist sector downturns2025 Top Gainers & Expert-Curated Trade Recommendations - DonanımHaber
Kamada announces $10M-$14M extension of Canadian supply tender - TipRanks
Can Kamada Ltd. stock rebound after recent weaknessIndex Update & Consistent Return Strategy Ideas - Улправда
Breakout Watch: Is Kamada Ltd. stock positioned well for digital economyJuly 2025 News Drivers & Growth Focused Entry Point Reports - Улправда
Kamada secures $10-14 million Canadian supply tender extension By Investing.com - Investing.com Nigeria
Kamada Ltd. Announces $10 Million to $14 Million Extension of Canadian Supply Tender - marketscreener.com
Kamada Receives Two-Year Supply Extension From Canadian Blood Services for Plasma-Derived Products - marketscreener.com
Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender - TipRanks
Kamada secures $10-14 million Canadian supply tender extension - Investing.com
Kamada (KMDA) announces $10–$14 million extension of Canadian tender - Stock Titan
Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewswire
Finanzdaten der Kamada Ltd-Aktie (KMDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):